Cell culture is the process by which cells are grown under controlled conditions outside of their natural environment. It enables scientists to study the normal physiology and biochemistry of cells and tissues outside the body. Cell culture products such as media, sera, reagents, equipment, and accessories are widely used in research, drug development, diagnostics, and manufacturing applications. Advances in cell culture techniques such as 3D cell culturing have increased the demand for cell culture products. The global cell culture market is estimated to be valued at US$ 19,198.0 Mn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the major trends driving the growth of the cell culture market is the advancements in 3D cell cultivation techniques. 3D cell cultures more closely mimic the physiological condition in vivo compared to 2D cultures. They enable multilayered cell growth in a 3D environment and cellular interactions similar to native tissue. Various innovative 3D culturing techniques such as scaffold-based cultures, microfluidic 3D cultures, magnetic 3D bioassemblies, and hanging drop plates have been developed. For instance, scaffold-based 3D cultures use biocompatible scaffolds to provide structural support and biochemical cues to guide cellular organization and functions. Companies are focusing on developing novel 3D culture products and systems to facilitate tissue engineering and cancer research applications. Growing adoption of 3D cell cultures is expected to boost the demand for associated cell culture products and accelerate the growth of the market over the forecast period.
Segment Analysis
The global cell culture market is segmented by product, application and end user. Based on product, consumables segment holds a dominating position in the market owing to its wide scale applications and repetitive purchase requirement. Consumables include media, sera, reagents and bioprocess containers which are highly used for cell culture processes. By application, biopharmaceutical production segment dominates the market due to increasing expenditure on biopharmaceutical R&D. Based on end user, pharmaceutical & biotechnology companies segment captures a lion share of the market as cell culture finds widespread application in this segment for drug discovery, vaccine production and therapeutic protein production.
Key Takeaways
Regional analysis: North America dominates the global cell culture market. This is attributed to growing biopharmaceutical industry and rising R&D expenditure in the region. Growing burden of chronic diseases, early adoption of advanced technologies and presence of key market participants also support dominance of North America. Asia Pacific region is projected to witness fastest growth over the forecast period due to growing biotechnology industry, increasing healthcare expenditure and expanding R&D activities in the region.
Key players: The global cell culture market is consolidated in nature with presence of few key players. Key players operating in the cell culture market are Corning Incorporated, Merck KGaA, Sartorius AG, BioSpherix, Ltd., Cell Culture Company, LLC, Thermo Fisher Scientific Inc., VWR International LLC, and Lonza. These companies are engaged in new product launches, expansions and partnerships to strengthen their market position. For instance, in 2023, Corning Incorporated launched Corning Cryogenic Cell Storage Vials to support long-term cell and tissue storage.
The global cell culture market is expected to witness high growth over the forecast period of 2023 to 2030. Market growth is driven by factors such as increasing R&D spending in pharmaceutical industry, focus on developing advanced cell-based therapies and vaccines, and growing demand for monoclonal antibodies.
